HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $50 Price Target
Alto Neuroscience, Inc.
Alto Neuroscience, Inc. ANRO | 0.00 |
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE:
ANRO) with a Buy and maintains $50 price target.
